305 related articles for article (PubMed ID: 10471053)
1. Expression of cyclins A and D and p21(waf1/cip1) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival.
Aaltomaa S; Lipponen P; Ala-Opas M; Eskelinen M; Syrjänen K; Kosma VM
Br J Cancer; 1999 Aug; 80(12):2001-7. PubMed ID: 10471053
[TBL] [Abstract][Full Text] [Related]
2. p21(WAF1/CIP1) expression in stage I cutaneous malignant melanoma: its relationship with p53, cell proliferation and survival.
Karjalainen JM; Eskelinen MJ; Kellokoski JK; Reinikainen M; Alhava EM; Kosma VM
Br J Cancer; 1999 Feb; 79(5-6):895-902. PubMed ID: 10070887
[TBL] [Abstract][Full Text] [Related]
3. Correlation and prognostic significance of p53, p21WAF1/CIP1 and Ki-67 expression in patients with superficial bladder tumors treated with bacillus Calmette-Guerin intravesical therapy.
Zlotta AR; Noel JC; Fayt I; Drowart A; Van Vooren JP; Huygen K; Simon J; Schulman CC
J Urol; 1999 Mar; 161(3):792-8. PubMed ID: 10022686
[TBL] [Abstract][Full Text] [Related]
4. Expression of cyclin D1, but not cyclins E and A, is related to progression in bilharzial bladder cancer.
Osman I; Scher H; Zhang ZF; Soos TJ; Hamza R; Eissa S; Khaled H; Koff A; Cordon-Cardo C
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2247-51. PubMed ID: 9815621
[TBL] [Abstract][Full Text] [Related]
5. High levels of constitutive WAF1/Cip1 protein are associated with chemoresistance in acute myelogenous leukemia.
Zhang W; Kornblau SM; Kobayashi T; Gambel A; Claxton D; Deisseroth AB
Clin Cancer Res; 1995 Sep; 1(9):1051-7. PubMed ID: 9816079
[TBL] [Abstract][Full Text] [Related]
6. p21/WAF1 expression as related to p53, cell proliferation and prognosis in epithelial ovarian cancer.
Anttila MA; Kosma VM; Hongxiu J; Puolakka J; Juhola M; Saarikoski S; Syrjänen K
Br J Cancer; 1999 Apr; 79(11-12):1870-8. PubMed ID: 10206307
[TBL] [Abstract][Full Text] [Related]
7. p21waf1/cip1 and transforming growth factor beta 1 protein expression correlate with survival in non-small cell lung cancer.
Bennett WP; el-Deiry WS; Rush WL; Guinee DG; Freedman AN; Caporaso NE; Welsh JA; Jones RT; Borkowski A; Travis WD; Fleming MV; Trastek V; Pairolero PC; Tazelaar HD; Midthun D; Jett JR; Liotta LA; Harris CC
Clin Cancer Res; 1998 Jun; 4(6):1499-506. PubMed ID: 9626468
[TBL] [Abstract][Full Text] [Related]
8. Expression of cell-cycle regulators, cyclin E and p21WAF1/CIP1, potential prognostic markers for gastric cancer.
Jang SJ; Park YW; Park MH; Lee JD; Lee YY; Jung TJ; Kim IS; Choi IY; Ki M; Choi BY; Ahn MJ
Eur J Surg Oncol; 1999 Apr; 25(2):157-63. PubMed ID: 10218458
[TBL] [Abstract][Full Text] [Related]
9. Paradoxical correlations of cyclin-dependent kinase inhibitors p21waf1/cip1 and p27kip1 in metastatic colorectal carcinoma.
Cheng JD; Werness BA; Babb JS; Meropol NJ
Clin Cancer Res; 1999 May; 5(5):1057-62. PubMed ID: 10353738
[TBL] [Abstract][Full Text] [Related]
10. p21WAF1/Cip1 is associated with cyclin D1CCND1 expression and tubular differentiation but is independent of p53 overexpression in human breast carcinoma.
Rey MJ; Fernández PL; Jares P; Muñoz M; Nadal A; Peiró N; Nayach I; Mallofré C; Muntané J; Campo E; Estapé J; Cardesa A
J Pathol; 1998 Mar; 184(3):265-71. PubMed ID: 9614378
[TBL] [Abstract][Full Text] [Related]
11. Reduced p21(WAF1/CIP1) expression and p53 mutation in hepatocellular carcinomas.
Hui AM; Kanai Y; Sakamoto M; Tsuda H; Hirohashi S
Hepatology; 1997 Mar; 25(3):575-9. PubMed ID: 9049201
[TBL] [Abstract][Full Text] [Related]
12. Expression of p21(waf1/cip1) protein in transitional cell bladder tumours and its prognostic value.
Lipponen P; Aaltomaa S; Eskelinen M; Ala-Opas M; Kosma VM
Eur Urol; 1998 Sep; 34(3):237-43. PubMed ID: 9732201
[TBL] [Abstract][Full Text] [Related]
13. Expression and alteration of p53 and p21(waf1/cip1) influence the sensitivity of chemoradiation therapy for esophageal cancer.
Shimoyama S; Konishi T; Kawahara M; Aoki F; Harada N; Shimizu S; Murakami T; Kaminishi M
Hepatogastroenterology; 1998; 45(23):1497-504. PubMed ID: 9840093
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of p21(WAF1) and p53 expression in breast carcinoma: an immunohistochemical study in 261 patients with long-term follow-up.
Caffo O; Doglioni C; Veronese S; Bonzanini M; Marchetti A; Buttitta F; Fina P; Leek R; Morelli L; Palma PD; Harris AL; Barbareschi M
Clin Cancer Res; 1996 Sep; 2(9):1591-9. PubMed ID: 9816338
[TBL] [Abstract][Full Text] [Related]
15. p53, through p21 (WAF1/CIP1), induces cyclin D1 synthesis.
Chen X; Bargonetti J; Prives C
Cancer Res; 1995 Oct; 55(19):4257-63. PubMed ID: 7671232
[TBL] [Abstract][Full Text] [Related]
16. [Studies on recurrent breast cancer--clinicopathological factors and p53, p21Cip1/Waf1 and cyclin D1 protein expression].
Yamaguchi Y; Hirooka Y; Konishi I; Sato N; Suzuki K; Kaibara N
Gan To Kagaku Ryoho; 1999 Apr; 26(5):673-7. PubMed ID: 10234299
[TBL] [Abstract][Full Text] [Related]
17. p21WAF1/CIP1 expression in colorectal carcinoma correlates with advanced disease stage and p53 mutations.
Viale G; Pellegrini C; Mazzarol G; Maisonneuve P; Silverman ML; Bosari S
J Pathol; 1999 Feb; 187(3):302-7. PubMed ID: 10398083
[TBL] [Abstract][Full Text] [Related]
18. Cyclin D1 overexpression in primary hypopharyngeal carcinomas.
Masuda M; Hirakawa N; Nakashima T; Kuratomi Y; Komiyama S
Cancer; 1996 Aug; 78(3):390-5. PubMed ID: 8697381
[TBL] [Abstract][Full Text] [Related]
19. Expression of cyclin-dependent kinase inhibitor p21WAF1/CIP1 in non-neoplastic mucosa and neoplasia of the stomach: relationship with p53 status and proliferative activity.
Yasui W; Akama Y; Kuniyasu H; Yokozaki H; Semba S; Shimamoto F; Tahara E
J Pathol; 1996 Oct; 180(2):122-8. PubMed ID: 8976868
[TBL] [Abstract][Full Text] [Related]
20. [The significance of p21 expression in gastric cancer].
Aoyagi K; Koufuji K; Kodama I; Yano S; Ohta J; Takamiya H; Mizutani K; Murakami N; Takeda J; Shirouzu K; Nakashima A
Gan To Kagaku Ryoho; 1997 Jul; 24 Suppl 2():285-91. PubMed ID: 9263517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]